Search

everythinglearnresearchcommunity

for

Search:↓

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

People with alopecia have a higher risk of thyroid cancer.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Endocrine disorders can cause various skin and hair issues.

Post-steroid panniculitis is now rare because doctors taper steroids more carefully.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Five different TPO gene mutations were found in PCOS patients with thyroid hormone issues.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

SII is a useful and affordable tool to assess and monitor alopecia areata.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Many people in Saudi Arabia lack awareness of thyroid disease risk factors and symptoms, highlighting the need for better health education.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Thyroid problems can negatively affect women's reproductive health and pregnancy, and can cause symptoms like fatigue and depression, but not all women with these symptoms need treatment.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

A new patch can deliver stable antibodies over time for potential HIV treatment.